HomeCompareGNTW vs MRK

GNTW vs MRK: Dividend Comparison 2026

GNTW yields 66.67% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GNTW wins by $841.9K in total portfolio value
10 years
GNTW
GNTW
● Live price
66.67%
Share price
$3.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$898.6K
Annual income
$227,458.53
Full GNTW calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GNTW vs MRK

📍 GNTW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGNTWMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GNTW + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GNTW pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GNTW
Annual income on $10K today (after 15% tax)
$5,666.67/yr
After 10yr DRIP, annual income (after tax)
$193,339.75/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GNTW beats the other by $185,011.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GNTW + MRK for your $10,000?

GNTW: 50%MRK: 50%
100% MRK50/50100% GNTW
Portfolio after 10yr
$477.7K
Annual income
$118,628.34/yr
Blended yield
24.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GNTW
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GNTW buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGNTWMRK
Forward yield66.67%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$898.6K$56.8K
Annual income after 10y$227,458.53$9,798.13
Total dividends collected$759.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GNTW vs MRK ($10,000, DRIP)

YearGNTW PortfolioGNTW Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$17,367$6,666.67$11,206$366.19+$6.2KGNTW
2$29,403$10,820.35$12,650$502.35+$16.8KGNTW
3$48,582$17,120.96$14,407$694.19+$34.2KGNTW
4$78,421$26,438.17$16,585$967.82+$61.8KGNTW
5$123,795$39,884.53$19,342$1,363.89+$104.5KGNTW
6$191,303$58,842.62$22,913$1,947.19+$168.4KGNTW
7$289,676$84,982.16$27,662$2,823.89+$262.0KGNTW
8$430,218$120,263.91$34,159$4,173.35+$396.1KGNTW
9$627,260$166,927.04$43,337$6,308.80+$583.9KGNTW
10$898,627$227,458.53$56,776$9,798.13+$841.9KGNTW

GNTW vs MRK: Complete Analysis 2026

GNTWStock

Stemtech Corporation, a stem cell nutrition company, develops and sells various dietary supplements. It offers stemrelease3, a stem cell enhancer, which supports the body's natural renewal system, a general sense of wellbeing, and telomeres health, as well as promotes youthful and healthy aging; StemFlo that supports optimal blood and healthy stem cell flow, protect the cardiovascular system from oxidative damage, boosts vitality, and promotes healthy aging; and MigraStem, a natural source of potent antioxidants, phytonutrients, fiber, and polysaccharides, which optimizes the migration of stem cells, enhance the immune system performance, support detoxification and anti-oxidative functions, enhances healthy longevity, and provide vitality and well-being. The company also provides OraStem that protects, strengthens, rejuvenates, restores, and supports teeth and gum function from the cellular level, as well as offer anti-oxidative and anti-microbial protection, supports tooth strength with essential minerals, helps to remove stains, brightens teeth in a natural and non-abrasive way, and freshens breath; and D-Fuze, an electromagnetic frequency (EMF) filter that protects the body from potential harm by dispersing EMFs to lower the specific absorption rate. It serves customers in Australia, Canada, Ecuador, Malaysia, Mexico, Namibia, New Zealand, the Philippines, Singapore, South Africa, Taiwan, Togo, and the United States. The company was founded in 2005 and is based in Miramar, Florida.

Full GNTW Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GNTW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GNTW vs SCHDGNTW vs JEPIGNTW vs OGNTW vs KOGNTW vs MAINGNTW vs JNJGNTW vs ABBVGNTW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.